0QNA Stock Price, Chart, Stats & News

Basilea Pharmaceutica AG is a revenue-generating biopharmaceutical company dedicated to developing innovative products to meet critical medical needs in both cancer treatment (oncology) and the fight against infections (anti-infectives). The company offers Cresemba, an antifungal medication available in both intravenous and oral forms, used to treat invasive aspergillosis and mucormycosis in the United States and the European Union. Cresemba is also progressing through Phase III clinical trials in Japan for additional invasive fungal infections.